Genovis AB Financials
| GENO Stock | SEK 21.70 0.35 1.59% |
Genovis |
Understanding current and past Genovis AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genovis AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Genovis AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Genovis AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genovis AB. Check Genovis AB's Beneish M Score to see the likelihood of Genovis AB's management manipulating its earnings.
Genovis AB Stock Summary
Genovis AB competes with Cantargia, Vicore Pharma, BioInvent International, and BioArctic. Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0002485979 |
| Business Address | ScheelevAegen 2, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.genovis.com |
| Phone | 46 46 10 12 30 |
| Currency | SEK - Swedish Kronor |
You should never invest in Genovis AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genovis Stock, because this is throwing your money away. Analyzing the key information contained in Genovis AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genovis AB Key Financial Ratios
Genovis AB's financial ratios allow both analysts and investors to convert raw data from Genovis AB's financial statements into concise, actionable information that can be used to evaluate the performance of Genovis AB over time and compare it to other companies across industries.Genovis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genovis AB's current stock value. Our valuation model uses many indicators to compare Genovis AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genovis AB competition to find correlations between indicators driving Genovis AB's intrinsic value. More Info.Genovis AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genovis AB is roughly 2.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genovis AB's earnings, one of the primary drivers of an investment's value.Genovis AB Systematic Risk
Genovis AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genovis AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Genovis AB correlated with the market. If Beta is less than 0 Genovis AB generally moves in the opposite direction as compared to the market. If Genovis AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genovis AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genovis AB is generally in the same direction as the market. If Beta > 1 Genovis AB moves generally in the same direction as, but more than the movement of the benchmark.
Genovis AB March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genovis AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genovis AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genovis AB based on widely used predictive technical indicators. In general, we focus on analyzing Genovis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genovis AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0) | |||
| Maximum Drawdown | 38.55 | |||
| Value At Risk | (5.42) | |||
| Potential Upside | 6.16 |
Additional Tools for Genovis Stock Analysis
When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.